Literature DB >> 34474522

Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age (Endocrinol Metab 2021;36:401-12, Seung Hun Lee et al.).

Seung Hun Lee1, Jong Woo Kim2, Hyun-Ki Yoon2, Jung-Min Koh1, Chan Soo Shin3, Sang Wan Kim3,4, Jung Hee Kim3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34474522      PMCID: PMC8419612          DOI: 10.3803/EnM.2021.402

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


× No keyword cloud information.
We appreciate the insightful comments from Dr. Singhania regarding our recent publication. We reported that patients with hypokalemia, a plasma aldosterone concentration >30.0 ng/dL, and unilateral lesions on computed tomography were at high risk of unilateral primary aldosteronism regardless of age [1]. We would like to respond as follows. First, Dr. Singhania pointed out that the importance of hypokalemia in diagnosing primary aldosteronism—particularly unilateral adenoma—was overemphasized. We agree that the prevalence of hypokalemia was relatively low in patients with primary aldosteronism. However, the presence of hypokalemia might reflect the disease severity, and a recent clinical guideline suggested that the presence of hypokalemia enables bypassing confirmatory testing for primary aldosteronism [2]. Our study found that hypokalemia alone was not a significant predictor, but that it became a more significant predictor together with other criteria. Moreover, previous studies have suggested that hypokalemia is a significant predictor of unilateral primary aldosteronism [3-5]. Second, Dr. Singhania pointed out that confirmatory testing can be skipped in the clinical setting of hypertension, spontaneous hypokalemia with a plasma aldosterone concentration >555 pmol/L (>20 ng/dL), and plasma renin activity <1 ng/mL/hr (or a plasma renin concentration below the lower limit of the reference range). We also agree that confirmatory testing is not necessary for patients with primary aldosteronism, according to the previously-mentioned guideline [2]. However, our study included patients from 2000 to 2018, which included the period before the guideline was published. Thus, our two centers consistently conducted confirmatory tests in patients with primary aldosteronism. We deeply appreciate Dr. Singhania’s valuable comments, which enriched the understanding of our article.
  5 in total

1.  Development and validation of subtype prediction scores for the workup of primary aldosteronism.

Authors:  Hiroki Kobayashi; Masanori Abe; Masayoshi Soma; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Hironobu Umakoshi; Mika Tsuiki; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hirotaka Shibata; Kohei Kamemura; Toshihiko Yanase; Michio Otsuki; Yuichi Fujii; Koichi Yamamoto; Atsushi Ogo; Kazutaka Nanba; Akiyo Tanabe; Tomoko Suzuki; Mitsuhide Naruse
Journal:  J Hypertens       Date:  2018-11       Impact factor: 4.844

2.  Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.

Authors:  Hironobu Umakoshi; Tatsuki Ogasawara; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamto; Atsushi Ogo; Toshihiko Yanase; Shintaro Okamura; Shozo Miyauchi; Tomoko Suzuki; Mika Tsuiki; Mitsuhide Naruse
Journal:  Clin Endocrinol (Oxf)       Date:  2018-03-13       Impact factor: 3.478

3.  A clinical prediction score to diagnose unilateral primary aldosteronism.

Authors:  Elselien M Küpers; Laurence Amar; Alain Raynaud; Pierre-François Plouin; Olivier Steichen
Journal:  J Clin Endocrinol Metab       Date:  2012-08-23       Impact factor: 5.958

4.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

5.  Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age.

Authors:  Seung Hun Lee; Jong Woo Kim; Hyun-Ki Yoon; Jung-Min Koh; Chan Soo Shin; Sang Wan Kim; Jung Hee Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.